Vizient Expert to Moderate Panel at FDA’s Compounding Quality Center of Excellence Conference
2024年8月20日 - 7:00PM
ビジネスワイヤ(英語)
Vizient, Inc. is pleased to participate in the Food and Drug
Administration's (FDA) 2024 Compounding Quality Center of
Excellence Annual Conference, taking place August 21-23. This
year’s conference, themed “Learning and Collaborating: Driving
Toward the Future of Quality,” will be hosted in a hybrid
format.
The conference offers a platform for outsourcing facilities and
industry professionals to learn, network, and enhance the quality
of compounded drugs for patients in need. Highlights include
in-depth sessions on quality, current good manufacturing practice
requirements, and building future partnerships, along with
networking opportunities and educational sessions with FDA and
industry leaders.
On Wednesday, August 21 from 2:30-3:30 p.m. ET, Jenna Stern,
associate vice president of regulatory affairs and public policy,
will moderate a panel discussion titled “The Business Case for
Quality and Resilience,” which will explore different perspectives
regarding quality and resilience. The panel will feature a range of
experts, including those from outsourcing facilities and
hospitals.
“We thank the FDA for including Vizient in these vital
discussions, which are important to bridge gaps and bolster
communication between outsourcing facilities and hospitals and
health systems,” said Stern. “At Vizient, maintaining strong
collaboration with the FDA and industry partners is a priority, as
we continue to support our providers with the resources to access
compounded medications.”
The FDA Compounding Quality Center of Excellence was established
to proactively support outsourcing facilities and market
stakeholders in delivering quality prescription drugs to patients
in need. In addition to facilitating training and market research,
the Center engages industry partners through its annual conference
to promote the quality of compounded drugs.
Learn more about Vizient's Pharmacy Solutions and advocacy to
support providers.
About Vizient, Inc.
Vizient, Inc., the nation's largest provider-driven healthcare
performance improvement company, serves more than 65% of the
nation's acute care providers, including 97% of the nation's
academic medical centers, and more than 35% of the non-acute
market. The Vizient contract portfolio represents $140 billion in
annual purchasing volume enabling the delivery of cost-effective,
high-value care. With its acquisition of Kaufman Hall in 2024,
Vizient expanded its advisory services to help providers achieve
financial, strategic, clinical and operational excellence.
Headquartered in Irving, Texas, Vizient has offices throughout the
United States. Learn more at www.vizientinc.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240820121023/en/
Donna Ledbetter (972) 830-6321
donna.ledbetter@vizientinc.com